Terumo Corporation (TRUMY)
Terumo Corporation operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Tokyo, TY, JP. The stock last traded at $16.32, down 0.06% on the session, giving a market capitalisation of $24.07B. On trailing twelve-month figures it carries a trailing P/E of 23.30, a net margin of 13.9%. Its beta of 0.23 implies it has historically moved less than the broad market.
Terumo Corporation is a global medical technology company dedicated to the manufacturing and sale of a wide array of medical products and equipment, operating through three distinct business segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular division provides critical devices for cardiovascular and cerebrovascular interventions, including angiographic guidewires, various catheters (angiographic, PTCA balloon, imaging), introducer sheaths, vascular closure devices, coronary and self-expanding peripheral stents, and intravascular ultrasound systems; it also develops specialized tools for cerebral aneurysm treatment like coils, stents, and intrasaccular devices, as well as embolization systems, aspiration catheters, and clot retrievers for ischemic stroke, further supplying oxygenators, cardio-pulmonary bypass systems, and artificial vascular and stent grafts. The Medical Care Solutions segment offers a comprehensive range of general medical products such as syringes, infusion and syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritional products, and adhesion barriers; for patient self-care, it provides blood glucose monitoring systems, disposable needles for pen-injectors, insulin patch pumps, blood pressure monitors, and digital thermometers, while also performing contract manufacturing for pharmaceutical companies, producing prefillable syringes and needles for drug packaging. The Blood and Cell Technologies division focuses on innovations in blood and cell management, offering products such as blood bags, component collection systems, automated blood processing and pathogen reduction systems, centrifugal apheresis systems, and cell expansion systems. Originally founded in 1921 as Sekisen Ken-onki Corporation, the company adopted the name Terumo Corporation in October 1974 and maintains its headquarters in Tokyo, Japan.
Terumo Corporation is most often compared with the following Healthcare names: